Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Emcore and Valeant are this weeks Blowouts
Brian Bolan is back with another edition of Bolan’s Blowouts. This time we are taking a look at Valeant Pharma and why it has been a Zacks Rank #5 (Strong Sell) for some time. Brian points to falling earnings estimates and then highlights who has been blowing out of the stock. Seems that Pershing Square has moved to sell more than 3M shares of this stock so this is only a partial blow out of a position that was more than 18M shares at one point.
Next is the stock that has seen a blowout earnings performance. Brian highlights Emcore (EMKR - Free Report) which is up about 44% since the report. The key to the report was the higher guidance for revenue and Brian has a special chart just to show how revenue expectations have trended of late.
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +26% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 11X worse than the market. See these critical buys and sells free >>